Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Cash from Financing Activities of $5.1 million for Q2 2024, down 47.01% on a QoQ basis from $9.6 million in Q1 2024.
Adagio Medical Holdings (ADGM) has 2 years of Cash from Financing Activities data on file, last reported at $5.1 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Adagio Medical Holdings | 16.86 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Dec 31, 2023 | 6.58 Mn |
| Dec 31, 2023 | 6.58 Mn |